Open-label, investigator-initiated, single-site exploratory trial evaluating secukinumab, an anti-interleukin-17A monoclonal antibody, for patients with moderate-to-severe hidradenitis suppurativa

L. Prussick; B. Rothstein; D. Joshipura; A. Saraiya; Y. Turkowski; R. Abdat; A. Alomran; P. Zancanaro; C. Kachuk; N. Dumont; A. B. Gottlieb; D. Rosmarin

doi:10.1111/bjd.17822

Open-label, investigator-initiated, single-site exploratory trial evaluating secukinumab, an anti-interleukin-17A monoclonal antibody, for patients with moderate-to-severe hidradenitis suppurativa

L. Prussick, B. Rothstein, D. Joshipura, A. Saraiya, Y. Turkowski, R. Abdat, A. Alomran, P. Zancanaro, C. Kachuk, N. Dumont, A. B. Gottlieb, D. Rosmarin

Research output: Contribution to journal › Letter › peer-review

78 Scopus citations

Original language	English
Pages (from-to)	609-611
Number of pages	3
Journal	British Journal of Dermatology
Volume	181
Issue number	3
DOIs	https://doi.org/10.1111/bjd.17822
State	Published - 1 Sep 2019

Access to Document

10.1111/bjd.17822

Cite this

Prussick, L., Rothstein, B., Joshipura, D., Saraiya, A., Turkowski, Y., Abdat, R., Alomran, A., Zancanaro, P., Kachuk, C., Dumont, N., Gottlieb, A. B., & Rosmarin, D. (2019). Open-label, investigator-initiated, single-site exploratory trial evaluating secukinumab, an anti-interleukin-17A monoclonal antibody, for patients with moderate-to-severe hidradenitis suppurativa. British Journal of Dermatology, 181(3), 609-611. https://doi.org/10.1111/bjd.17822

@article{c91b1a5a7d8d4bc8a3d57952391bbf0f,

title = "Open-label, investigator-initiated, single-site exploratory trial evaluating secukinumab, an anti-interleukin-17A monoclonal antibody, for patients with moderate-to-severe hidradenitis suppurativa",

author = "L. Prussick and B. Rothstein and D. Joshipura and A. Saraiya and Y. Turkowski and R. Abdat and A. Alomran and P. Zancanaro and C. Kachuk and N. Dumont and Gottlieb, {A. B.} and D. Rosmarin",

year = "2019",

month = sep,

day = "1",

doi = "10.1111/bjd.17822",

language = "English",

volume = "181",

pages = "609--611",

journal = "British Journal of Dermatology",

issn = "0007-0963",

publisher = "Oxford University Press",

number = "3",

}

Prussick, L, Rothstein, B, Joshipura, D, Saraiya, A, Turkowski, Y, Abdat, R, Alomran, A, Zancanaro, P, Kachuk, C, Dumont, N, Gottlieb, AB & Rosmarin, D 2019, 'Open-label, investigator-initiated, single-site exploratory trial evaluating secukinumab, an anti-interleukin-17A monoclonal antibody, for patients with moderate-to-severe hidradenitis suppurativa', British Journal of Dermatology, vol. 181, no. 3, pp. 609-611. https://doi.org/10.1111/bjd.17822

Open-label, investigator-initiated, single-site exploratory trial evaluating secukinumab, an anti-interleukin-17A monoclonal antibody, for patients with moderate-to-severe hidradenitis suppurativa. / Prussick, L.; Rothstein, B.; Joshipura, D. et al.
In: British Journal of Dermatology, Vol. 181, No. 3, 01.09.2019, p. 609-611.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - Open-label, investigator-initiated, single-site exploratory trial evaluating secukinumab, an anti-interleukin-17A monoclonal antibody, for patients with moderate-to-severe hidradenitis suppurativa

AU - Prussick, L.

AU - Rothstein, B.

AU - Joshipura, D.

AU - Saraiya, A.

AU - Turkowski, Y.

AU - Abdat, R.

AU - Alomran, A.

AU - Zancanaro, P.

AU - Kachuk, C.

AU - Dumont, N.

AU - Gottlieb, A. B.

AU - Rosmarin, D.

PY - 2019/9/1

Y1 - 2019/9/1

UR - http://www.scopus.com/inward/record.url?scp=85065768599&partnerID=8YFLogxK

U2 - 10.1111/bjd.17822

DO - 10.1111/bjd.17822

M3 - Letter

C2 - 30801662

AN - SCOPUS:85065768599

SN - 0007-0963

VL - 181

SP - 609

EP - 611

JO - British Journal of Dermatology

JF - British Journal of Dermatology

IS - 3

ER -